SCHEMBL4551236

SCHEMBL4551236

O=C(O)N1CCN(C(=O)c2ccc(-c3cc(Cl)c(CC4CCN(C5CCCCC5)C4=O)c(Cl)c3)cc2)CC1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 1/20 0.46
FASN P49327 1/20 0.40
KDM4E B2RXH2 4/20 0.39
ALDH1A1 P00352 3/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
KMT2A Q03164 1/20 0.39
POLB P06746 1/20 0.39
PDE5A O76074 1/20 0.39
PDE4A P27815 1/20 0.39
PDE1A P54750 1/20 0.39
PDE1B Q01064 1/20 0.39
PDE4B Q07343 1/20 0.39
PDE4C Q08493 1/20 0.39
PDE4D Q08499 1/20 0.39
PDE7A Q13946 1/20 0.39
PDE1C Q14123 1/20 0.39
PDE3A Q14432 1/20 0.39
PDE7B Q9NP56 1/20 0.39
L3MBTL3 Q96JM7 2/20 0.38
HTT P42858 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL210606 0.93 HSD11B1 (0.46) HSD11B1ALDH1A1L3MBTL1KMT2AL3MBTL3
SCHEMBL208680 0.93 HSD11B1 (0.46) HSD11B1FASNALDH1A1L3MBTL1KMT2A
SCHEMBL208807 0.93 HSD11B1 (0.46) HSD11B1ALDH1A1L3MBTL1KMT2AL3MBTL3
SCHEMBL15216493 0.93 HSD11B1 (0.43) HSD11B1FASNKDM4EALDH1A1L3MBTL1
SCHEMBL210019 0.92 HSD11B1 (0.43) HSD11B1FASNKDM4EALDH1A1L3MBTL1
SCHEMBL211080 0.92 PDE5A (0.48) HSD11B1ALDH1A1L3MBTL1KMT2APOLB
SCHEMBL209326 0.92 HSD11B1 (0.43) HSD11B1FASNKDM4EALDH1A1L3MBTL1
SCHEMBL208724 0.91 HSD11B1 (0.44) HSD11B1FASNKDM4EALDH1A1L3MBTL1
Hydrochloric Acid SCHEMBL207291 0.91 PDE5A (0.47) HSD11B1ALDH1A1L3MBTL1KMT2APOLB
SCHEMBL208997 0.91 HSD11B1 (0.43) HSD11B1KDM4EALDH1A1L3MBTL1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2016047-B1 BIPHENYL AMIDE LACTAM DERIVATIVES AS INHIBITORS OF 11- BETA-HYDROXYSTEROID DEHYDROGENASE 1 LILLY CO ELI (US) 2013-08-28 EP claimed
US-20090156571-A1 BIPHENYL AMIDE LACTAM DERIVATIVES AS INHIBITORS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE 1 ELI LILLY AND COMPANY 2009-06-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090156571-A1 BIPHENYL AMIDE LACTAM DERIVATIVES AS INHIBITORS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE 1 HSD11B1, HSD17B1, HSD11B2 HSD11B1 1/4885FASN 210/4885KDM4E 1143/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.